Ghandehari Kavian, Ahmadi Fahimeh, Afzalnia Azadeh
Neuroscience Research Center, Department of Neurology, Mashhad University of Medical Sciences, Mashhad 91766-99199, Iran.
Stroke Res Treat. 2011;2011:560831. doi: 10.4061/2011/560831. Epub 2011 May 4.
Background. The impact of invasive methods of treatment on results in developing countries may differ from that in developed countries. Methods. This is a prospective clinical study of consecutive patients with Subarachnoid Haemorrhage (SAH) admitted to the Ghaem Hospital, Mashhad during the period from 2005 to 2009. The initial diagnosis and investigations were carried out by neurologists. The patients were divided into two groups. One received surgical treatment whilst the other group was managed medically. The decision as to the choice of the method of treatment was made by the neurosurgeons. The initial medical treatment was standardised for all the patients. The rate of complications and mortality was compared in both medical and surgical groups. Results. 120 SAH patients (52% females) with a mean age of 50.6 ± 7 years were evaluated. The angiography revealed the presence of an aneurysm in 62 patients. 63.5% of the patients received medical treatment and 37.5% underwent aneurysmal surgery. Difference of rebleeding rate in the two therapeutic groups was not significant; X(2) = .014, P = .91. The effect of rebleeding on mortality was not significant; X(2) = 2.54, P = .14. Within 62 SAH patients with cerebral aneurysm, the mortality rate in both therapeutic groups was also not significantly different; X(2) = .16, P = .77. Conclusion. There is no significant difference in the mortality rate between the "surgical" and non-"surgical" groups of Iranian patients with SAH. This could be due to delay in performance of surgery in Iranian neurovascular centers.
背景。在发展中国家,侵入性治疗方法对治疗结果的影响可能与发达国家不同。方法。这是一项对2005年至2009年期间入住马什哈德加姆医院的连续蛛网膜下腔出血(SAH)患者进行的前瞻性临床研究。初始诊断和检查由神经科医生进行。患者分为两组。一组接受手术治疗,另一组接受药物治疗。治疗方法的选择由神经外科医生决定。所有患者的初始药物治疗均标准化。比较药物治疗组和手术治疗组的并发症发生率和死亡率。结果。对120例SAH患者(52%为女性)进行了评估,平均年龄为50.6±7岁。血管造影显示62例患者存在动脉瘤。63.5%的患者接受药物治疗,37.5%的患者接受动脉瘤手术。两个治疗组再出血率的差异无统计学意义;X(2)=.014,P=.91。再出血对死亡率的影响无统计学意义;X(2)=2.54,P=.14。在62例患有脑动脉瘤的SAH患者中,两个治疗组的死亡率也无显著差异;X(2)=.16,P=.77。结论。伊朗SAH患者的“手术”组和非“手术”组死亡率无显著差异。这可能是由于伊朗神经血管中心手术延迟所致。